nodes	percent_of_prediction	percent_of_DWPC	metapath
Minaprine—Gefitinib—Erlotinib—pancreatic cancer	0.781	1	CrCrCtD
Minaprine—ACHE—Irinotecan—pancreatic cancer	0.0982	0.701	CbGbCtD
Minaprine—CYP2D6—Tamoxifen—pancreatic cancer	0.0184	0.132	CbGbCtD
Minaprine—CYP2D6—Erlotinib—pancreatic cancer	0.0157	0.112	CbGbCtD
Minaprine—CYP2D6—Doxorubicin—pancreatic cancer	0.00773	0.0552	CbGbCtD
Minaprine—Gefitinib—EGFR—pancreatic cancer	0.000519	1	CrCbGaD
Minaprine—HTR2A—GPCR downstream signaling—PIK3CB—pancreatic cancer	1.09e-05	0.00014	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—PIK3CG—pancreatic cancer	1.09e-05	0.00014	CbGpPWpGaD
Minaprine—HTR2B—Signaling by GPCR—NRAS—pancreatic cancer	1.09e-05	0.00014	CbGpPWpGaD
Minaprine—CHRM1—GPCR downstream signaling—PIK3CB—pancreatic cancer	1.09e-05	0.000139	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—EGF—pancreatic cancer	1.08e-05	0.000138	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—SMAD4—pancreatic cancer	1.08e-05	0.000138	CbGpPWpGaD
Minaprine—DRD2—GPCR downstream signaling—CXCL8—pancreatic cancer	1.07e-05	0.000136	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—NFKBIA—pancreatic cancer	1.06e-05	0.000136	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—SMAD4—pancreatic cancer	1.06e-05	0.000136	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—SMAD4—pancreatic cancer	1.05e-05	0.000135	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—HES1—pancreatic cancer	1.05e-05	0.000135	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—NOTCH1—pancreatic cancer	1.05e-05	0.000135	CbGpPWpGaD
Minaprine—HTR2A—GPCR downstream signaling—CXCL8—pancreatic cancer	1.05e-05	0.000134	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—TERT—pancreatic cancer	1.04e-05	0.000134	CbGpPWpGaD
Minaprine—CHRM1—GPCR downstream signaling—CXCL8—pancreatic cancer	1.04e-05	0.000134	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—HES1—pancreatic cancer	1.03e-05	0.000133	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—HES1—pancreatic cancer	1.03e-05	0.000132	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—PIK3CG—pancreatic cancer	1.03e-05	0.000132	CbGpPWpGaD
Minaprine—DRD1—Signaling by GPCR—NRAS—pancreatic cancer	1.03e-05	0.000132	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—EGF—pancreatic cancer	1.02e-05	0.00013	CbGpPWpGaD
Minaprine—ACHE—Metabolism—PIK3CB—pancreatic cancer	1.01e-05	0.00013	CbGpPWpGaD
Minaprine—DRD2—Signaling by GPCR—PIK3CB—pancreatic cancer	1.01e-05	0.000129	CbGpPWpGaD
Minaprine—ACHE—Metabolism—PTGS2—pancreatic cancer	1e-05	0.000128	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—HIF1A—pancreatic cancer	9.98e-06	0.000128	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—TSC2—pancreatic cancer	9.96e-06	0.000128	CbGpPWpGaD
Minaprine—HTR2B—Signaling by GPCR—EGFR—pancreatic cancer	9.93e-06	0.000127	CbGpPWpGaD
Minaprine—HTR2A—Signaling by GPCR—PIK3CB—pancreatic cancer	9.91e-06	0.000127	CbGpPWpGaD
Minaprine—CHRM1—Signaling by GPCR—PIK3CB—pancreatic cancer	9.85e-06	0.000126	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—APOE—pancreatic cancer	9.75e-06	0.000125	CbGpPWpGaD
Minaprine—DRD2—Signaling by GPCR—CXCL8—pancreatic cancer	9.68e-06	0.000124	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—PIK3CD—pancreatic cancer	9.58e-06	0.000123	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—KDR—pancreatic cancer	9.55e-06	0.000122	CbGpPWpGaD
Minaprine—MAOA—Metabolism—PIK3CB—pancreatic cancer	9.53e-06	0.000122	CbGpPWpGaD
Minaprine—HTR2A—Signaling by GPCR—CXCL8—pancreatic cancer	9.52e-06	0.000122	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—CD44—pancreatic cancer	9.52e-06	0.000122	CbGpPWpGaD
Minaprine—HTR2B—GPCR downstream signaling—PIK3CA—pancreatic cancer	9.49e-06	0.000122	CbGpPWpGaD
Minaprine—CHRM1—Signaling by GPCR—CXCL8—pancreatic cancer	9.47e-06	0.000121	CbGpPWpGaD
Minaprine—MAOA—Metabolism—PTGS2—pancreatic cancer	9.44e-06	0.000121	CbGpPWpGaD
Minaprine—HTR2B—Signaling by GPCR—KRAS—pancreatic cancer	9.38e-06	0.00012	CbGpPWpGaD
Minaprine—DRD1—Signaling by GPCR—EGFR—pancreatic cancer	9.37e-06	0.00012	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—TERT—pancreatic cancer	9.21e-06	0.000118	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—GCG—pancreatic cancer	9.12e-06	0.000117	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—NFKBIA—pancreatic cancer	9.08e-06	0.000116	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—TERT—pancreatic cancer	9.07e-06	0.000116	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—PIK3CD—pancreatic cancer	9.04e-06	0.000116	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—TERT—pancreatic cancer	9.02e-06	0.000115	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—NOTCH1—pancreatic cancer	8.99e-06	0.000115	CbGpPWpGaD
Minaprine—DRD1—GPCR downstream signaling—PIK3CA—pancreatic cancer	8.95e-06	0.000115	CbGpPWpGaD
Minaprine—DRD1—Signaling by GPCR—KRAS—pancreatic cancer	8.85e-06	0.000113	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—HIF1A—pancreatic cancer	8.81e-06	0.000113	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—PIK3CG—pancreatic cancer	8.8e-06	0.000113	CbGpPWpGaD
Minaprine—HTR2C—Signaling by GPCR—NRAS—pancreatic cancer	8.8e-06	0.000113	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—TSC2—pancreatic cancer	8.79e-06	0.000113	CbGpPWpGaD
Minaprine—ACHE—Metabolism—PTEN—pancreatic cancer	8.74e-06	0.000112	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—EGF—pancreatic cancer	8.69e-06	0.000111	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—HIF1A—pancreatic cancer	8.67e-06	0.000111	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—TSC2—pancreatic cancer	8.65e-06	0.000111	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—HIF1A—pancreatic cancer	8.62e-06	0.00011	CbGpPWpGaD
Minaprine—HTR2B—Signaling by GPCR—PIK3CA—pancreatic cancer	8.62e-06	0.00011	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—TSC2—pancreatic cancer	8.6e-06	0.00011	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—APOE—pancreatic cancer	8.6e-06	0.00011	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—STK11—pancreatic cancer	8.58e-06	0.00011	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—APOE—pancreatic cancer	8.46e-06	0.000108	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—KDR—pancreatic cancer	8.43e-06	0.000108	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—APOE—pancreatic cancer	8.42e-06	0.000108	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—PIK3CB—pancreatic cancer	8.35e-06	0.000107	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—KDR—pancreatic cancer	8.29e-06	0.000106	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—KDR—pancreatic cancer	8.25e-06	0.000106	CbGpPWpGaD
Minaprine—MAOA—Metabolism—PTEN—pancreatic cancer	8.24e-06	0.000105	CbGpPWpGaD
Minaprine—DRD1—Signaling by GPCR—PIK3CA—pancreatic cancer	8.13e-06	0.000104	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—CXCL8—pancreatic cancer	8.03e-06	0.000103	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—NFKBIA—pancreatic cancer	8.02e-06	0.000103	CbGpPWpGaD
Minaprine—HTR2C—Signaling by GPCR—EGFR—pancreatic cancer	8.01e-06	0.000103	CbGpPWpGaD
Minaprine—HTR2B—Signaling by GPCR—HRAS—pancreatic cancer	7.98e-06	0.000102	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—NOTCH1—pancreatic cancer	7.94e-06	0.000102	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—NFKBIA—pancreatic cancer	7.89e-06	0.000101	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—PIK3CB—pancreatic cancer	7.88e-06	0.000101	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—NFKBIA—pancreatic cancer	7.84e-06	0.0001	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—NOTCH1—pancreatic cancer	7.81e-06	0.0001	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—NOTCH1—pancreatic cancer	7.77e-06	9.95e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—PIK3CG—pancreatic cancer	7.76e-06	9.94e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling by GPCR—NRAS—pancreatic cancer	7.76e-06	9.94e-05	CbGpPWpGaD
Minaprine—HTR2B—GPCR downstream signaling—AKT1—pancreatic cancer	7.76e-06	9.93e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—PIK3CD—pancreatic cancer	7.73e-06	9.9e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—CASP3—pancreatic cancer	7.68e-06	9.84e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—EGF—pancreatic cancer	7.67e-06	9.83e-05	CbGpPWpGaD
Minaprine—HTR2C—GPCR downstream signaling—PIK3CA—pancreatic cancer	7.66e-06	9.81e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—PIK3CG—pancreatic cancer	7.64e-06	9.78e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling by GPCR—NRAS—pancreatic cancer	7.64e-06	9.78e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—PIK3CG—pancreatic cancer	7.6e-06	9.73e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling by GPCR—NRAS—pancreatic cancer	7.6e-06	9.73e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—CXCL8—pancreatic cancer	7.57e-06	9.7e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling by GPCR—KRAS—pancreatic cancer	7.57e-06	9.7e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—EGF—pancreatic cancer	7.55e-06	9.67e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling by GPCR—HRAS—pancreatic cancer	7.52e-06	9.63e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—EGF—pancreatic cancer	7.51e-06	9.62e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—CCND1—pancreatic cancer	7.48e-06	9.58e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—CTNNB1—pancreatic cancer	7.41e-06	9.49e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—TYMS—pancreatic cancer	7.38e-06	9.45e-05	CbGpPWpGaD
Minaprine—DRD1—GPCR downstream signaling—AKT1—pancreatic cancer	7.31e-06	9.37e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—MMP9—pancreatic cancer	7.26e-06	9.3e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—CASP3—pancreatic cancer	7.25e-06	9.28e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—PTEN—pancreatic cancer	7.22e-06	9.25e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling by GPCR—EGFR—pancreatic cancer	7.07e-06	9.06e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—CCND1—pancreatic cancer	7.05e-06	9.03e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling by GPCR—AKT1—pancreatic cancer	7.04e-06	9.02e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—CTNNB1—pancreatic cancer	6.98e-06	8.95e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling by GPCR—EGFR—pancreatic cancer	6.96e-06	8.91e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling by GPCR—PIK3CA—pancreatic cancer	6.96e-06	8.91e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling by GPCR—EGFR—pancreatic cancer	6.92e-06	8.87e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—MMP9—pancreatic cancer	6.85e-06	8.77e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—PIK3CD—pancreatic cancer	6.82e-06	8.74e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—PTEN—pancreatic cancer	6.81e-06	8.72e-05	CbGpPWpGaD
Minaprine—DRD2—GPCR downstream signaling—PIK3CA—pancreatic cancer	6.76e-06	8.66e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—PIK3CB—pancreatic cancer	6.74e-06	8.63e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—PIK3CD—pancreatic cancer	6.71e-06	8.6e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—SRC—pancreatic cancer	6.69e-06	8.57e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling by GPCR—KRAS—pancreatic cancer	6.68e-06	8.56e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—PIK3CD—pancreatic cancer	6.68e-06	8.55e-05	CbGpPWpGaD
Minaprine—HTR2A—GPCR downstream signaling—PIK3CA—pancreatic cancer	6.65e-06	8.52e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling by GPCR—AKT1—pancreatic cancer	6.64e-06	8.51e-05	CbGpPWpGaD
Minaprine—CHRM1—GPCR downstream signaling—PIK3CA—pancreatic cancer	6.62e-06	8.47e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling by GPCR—KRAS—pancreatic cancer	6.57e-06	8.42e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling by GPCR—KRAS—pancreatic cancer	6.54e-06	8.37e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—VEGFA—pancreatic cancer	6.52e-06	8.35e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—CXCL8—pancreatic cancer	6.48e-06	8.3e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—STAT3—pancreatic cancer	6.46e-06	8.27e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—NRAS—pancreatic cancer	6.44e-06	8.25e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling by GPCR—HRAS—pancreatic cancer	6.43e-06	8.24e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—SRC—pancreatic cancer	6.31e-06	8.09e-05	CbGpPWpGaD
Minaprine—HTR2C—GPCR downstream signaling—AKT1—pancreatic cancer	6.26e-06	8.01e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—CASP3—pancreatic cancer	6.2e-06	7.94e-05	CbGpPWpGaD
Minaprine—ACHE—Metabolism—PIK3CA—pancreatic cancer	6.17e-06	7.9e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—VEGFA—pancreatic cancer	6.15e-06	7.88e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling by GPCR—PIK3CA—pancreatic cancer	6.14e-06	7.86e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—STAT3—pancreatic cancer	6.09e-06	7.8e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—NRAS—pancreatic cancer	6.07e-06	7.78e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling by GPCR—PIK3CA—pancreatic cancer	6.04e-06	7.74e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—CCND1—pancreatic cancer	6.03e-06	7.73e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling by GPCR—PIK3CA—pancreatic cancer	6.01e-06	7.69e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—APOE—pancreatic cancer	6e-06	7.69e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—MYC—pancreatic cancer	6e-06	7.68e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—TGFB1—pancreatic cancer	5.98e-06	7.66e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—CTNNB1—pancreatic cancer	5.98e-06	7.65e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—PIK3CB—pancreatic cancer	5.95e-06	7.62e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—EGFR—pancreatic cancer	5.87e-06	7.52e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—MMP9—pancreatic cancer	5.86e-06	7.5e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—PIK3CB—pancreatic cancer	5.85e-06	7.5e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—PTEN—pancreatic cancer	5.82e-06	7.46e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—PIK3CB—pancreatic cancer	5.82e-06	7.46e-05	CbGpPWpGaD
Minaprine—MAOA—Metabolism—PIK3CA—pancreatic cancer	5.81e-06	7.44e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—CXCL8—pancreatic cancer	5.72e-06	7.32e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling by GPCR—AKT1—pancreatic cancer	5.68e-06	7.28e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling by GPCR—HRAS—pancreatic cancer	5.68e-06	7.27e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—MYC—pancreatic cancer	5.66e-06	7.25e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—TGFB1—pancreatic cancer	5.64e-06	7.23e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—CXCL8—pancreatic cancer	5.62e-06	7.2e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—CXCL8—pancreatic cancer	5.59e-06	7.16e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling by GPCR—HRAS—pancreatic cancer	5.59e-06	7.16e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling by GPCR—HRAS—pancreatic cancer	5.56e-06	7.12e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—KRAS—pancreatic cancer	5.54e-06	7.1e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—EGFR—pancreatic cancer	5.53e-06	7.09e-05	CbGpPWpGaD
Minaprine—DRD2—GPCR downstream signaling—AKT1—pancreatic cancer	5.52e-06	7.07e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—CASP3—pancreatic cancer	5.47e-06	7.01e-05	CbGpPWpGaD
Minaprine—HTR2A—GPCR downstream signaling—AKT1—pancreatic cancer	5.43e-06	6.96e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—PIK3CG—pancreatic cancer	5.42e-06	6.94e-05	CbGpPWpGaD
Minaprine—CHRM1—GPCR downstream signaling—AKT1—pancreatic cancer	5.4e-06	6.92e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—SRC—pancreatic cancer	5.4e-06	6.92e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—CASP3—pancreatic cancer	5.38e-06	6.89e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—CASP3—pancreatic cancer	5.35e-06	6.86e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—CCND1—pancreatic cancer	5.33e-06	6.82e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—CTNNB1—pancreatic cancer	5.27e-06	6.75e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—VEGFA—pancreatic cancer	5.26e-06	6.74e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—CCND1—pancreatic cancer	5.24e-06	6.71e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—KRAS—pancreatic cancer	5.23e-06	6.7e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—PPARG—pancreatic cancer	5.23e-06	6.69e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—CCND1—pancreatic cancer	5.21e-06	6.68e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—STAT3—pancreatic cancer	5.21e-06	6.67e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—NRAS—pancreatic cancer	5.2e-06	6.65e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—CTNNB1—pancreatic cancer	5.19e-06	6.65e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—MMP9—pancreatic cancer	5.17e-06	6.62e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—CTNNB1—pancreatic cancer	5.16e-06	6.61e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—PTEN—pancreatic cancer	5.14e-06	6.58e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—PIK3CA—pancreatic cancer	5.09e-06	6.52e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—MMP9—pancreatic cancer	5.09e-06	6.52e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—MMP9—pancreatic cancer	5.06e-06	6.48e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—PTEN—pancreatic cancer	5.06e-06	6.48e-05	CbGpPWpGaD
Minaprine—ACHE—Metabolism—AKT1—pancreatic cancer	5.04e-06	6.45e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—PTEN—pancreatic cancer	5.03e-06	6.44e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling by GPCR—AKT1—pancreatic cancer	5.01e-06	6.42e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling by GPCR—AKT1—pancreatic cancer	4.93e-06	6.32e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—TP53—pancreatic cancer	4.93e-06	6.31e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling by GPCR—AKT1—pancreatic cancer	4.91e-06	6.29e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—MYC—pancreatic cancer	4.84e-06	6.2e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—TGFB1—pancreatic cancer	4.83e-06	6.18e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—PIK3CA—pancreatic cancer	4.8e-06	6.15e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—SRC—pancreatic cancer	4.77e-06	6.11e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—PIK3CD—pancreatic cancer	4.76e-06	6.1e-05	CbGpPWpGaD
Minaprine—MAOA—Metabolism—AKT1—pancreatic cancer	4.75e-06	6.08e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—EGFR—pancreatic cancer	4.73e-06	6.06e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—HRAS—pancreatic cancer	4.71e-06	6.03e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—SRC—pancreatic cancer	4.69e-06	6.01e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—SRC—pancreatic cancer	4.67e-06	5.97e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—TP53—pancreatic cancer	4.65e-06	5.95e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—VEGFA—pancreatic cancer	4.64e-06	5.95e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—STAT3—pancreatic cancer	4.6e-06	5.89e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—NRAS—pancreatic cancer	4.59e-06	5.87e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—VEGFA—pancreatic cancer	4.57e-06	5.85e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—VEGFA—pancreatic cancer	4.54e-06	5.82e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—STAT3—pancreatic cancer	4.52e-06	5.79e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—NRAS—pancreatic cancer	4.51e-06	5.78e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—STAT3—pancreatic cancer	4.5e-06	5.76e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—NRAS—pancreatic cancer	4.49e-06	5.75e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—KRAS—pancreatic cancer	4.47e-06	5.73e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—HRAS—pancreatic cancer	4.44e-06	5.69e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—MYC—pancreatic cancer	4.27e-06	5.47e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—TGFB1—pancreatic cancer	4.26e-06	5.46e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—MYC—pancreatic cancer	4.2e-06	5.38e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—TGFB1—pancreatic cancer	4.19e-06	5.37e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—MYC—pancreatic cancer	4.18e-06	5.35e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—EGFR—pancreatic cancer	4.18e-06	5.35e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—TGFB1—pancreatic cancer	4.17e-06	5.34e-05	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—AKT1—pancreatic cancer	4.16e-06	5.33e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—PIK3CB—pancreatic cancer	4.15e-06	5.31e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—PTGS2—pancreatic cancer	4.11e-06	5.27e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—EGFR—pancreatic cancer	4.11e-06	5.27e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—PIK3CA—pancreatic cancer	4.11e-06	5.26e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—EGFR—pancreatic cancer	4.09e-06	5.24e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—TP53—pancreatic cancer	3.97e-06	5.09e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—KRAS—pancreatic cancer	3.95e-06	5.05e-05	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—AKT1—pancreatic cancer	3.92e-06	5.02e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—KRAS—pancreatic cancer	3.88e-06	4.97e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—KRAS—pancreatic cancer	3.86e-06	4.95e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—HRAS—pancreatic cancer	3.8e-06	4.87e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—PIK3CA—pancreatic cancer	3.63e-06	4.64e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—PTEN—pancreatic cancer	3.59e-06	4.59e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—PIK3CA—pancreatic cancer	3.57e-06	4.57e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—PIK3CA—pancreatic cancer	3.55e-06	4.55e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—TP53—pancreatic cancer	3.51e-06	4.49e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—TP53—pancreatic cancer	3.45e-06	4.42e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—TP53—pancreatic cancer	3.43e-06	4.4e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—AKT1—pancreatic cancer	3.36e-06	4.3e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—HRAS—pancreatic cancer	3.35e-06	4.3e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—HRAS—pancreatic cancer	3.3e-06	4.23e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—HRAS—pancreatic cancer	3.28e-06	4.21e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—AKT1—pancreatic cancer	2.96e-06	3.79e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—AKT1—pancreatic cancer	2.91e-06	3.73e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—AKT1—pancreatic cancer	2.9e-06	3.71e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—PIK3CA—pancreatic cancer	2.53e-06	3.24e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—AKT1—pancreatic cancer	2.07e-06	2.65e-05	CbGpPWpGaD
